Issue 3/2020
Content (10 Articles)
Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis
Manel Mejbri, Katerina Theodoropoulou, Michael Hofer, Rolando Cimaz
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
Stefania Costi, Roberto Caporali, Rolando Cimaz
Pharmacological Management of Pediatric Pustular Psoriasis
Yi-Wei Huang, Tsen-Fang Tsai
Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review
Jahidur Rashid, Shaun S. Kumar, Kathleen M. Job, Xiaoxi Liu, Candice D. Fike, Catherine M. T. Sherwin
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents
Amelia Licari, Riccardo Castagnoli, Alessia Marseglia, Francesca Olivero, Martina Votto, Giorgio Ciprandi, Gian Luigi Marseglia
The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders
Quoc-Bao D. Nguyen, Caroline T. Starling, Adelaide A. Hebert
A Prospective Cohort Study of Factors Associated with Empiric Antibiotic De-escalation in Neonates Suspected with Early Onset Sepsis (EOS)
Nazedah Ain Ibrahim, Mohd Makmor Bakry, Nurul Ain Mohd Tahir, Nur Rashidah Mohd Zaini, Noraida Mohamed Shah
The Role of Oral Administration of Immunoglobulin in Managing Diarrheal Illness in Immunocompromised Children
Erin Alexander, Salim Hommeida, Michael C. Stephens, Mhd Louai Manini, Imad Absah
Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group
Nikita Bhoombla, Jennifer Preston, Jenny Ainsworth, Helena Bird, Mitul Jadeja, Charlotte King, Daniel B. Hawcutt